Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
CellSource Co., Ltd. ( (JP:4880) ) just unveiled an announcement.
CellSource Co., Ltd. has finalized the terms for its stock acquisition rights, initially resolved at a Board of Directors meeting on June 12, 2025. The finalized terms involve two employees receiving a total of 1,582 stock acquisition rights, with an exercise price set at 68,200 yen per right, equivalent to 682 yen per share.
The most recent analyst rating on (JP:4880) stock is a Hold with a Yen880.00 price target. To see the full list of analyst forecasts on CellSource Co., Ltd. stock, see the JP:4880 Stock Forecast page.
More about CellSource Co., Ltd.
Average Trading Volume: 67,941
Technical Sentiment Signal: Sell
Current Market Cap: Yen13.49B
See more data about 4880 stock on TipRanks’ Stock Analysis page.